Girard Partners’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $3.21M | Sell |
21,976
-991
| -4% | -$147K | 0.3% | 66 |
|
|
2024
Q1 | $3.63M | Buy |
22,967
+3,432
| +18% | +$546K | 0.34% | 65 |
|
|
2023
Q4 | $3.06M | Sell |
19,535
-2,085
| -10% | -$320K | 0.31% | 69 |
|
|
2023
Q3 | $3.37M | Sell |
21,620
-1,744
| -7% | -$288K | 0.38% | 59 |
|
|
2023
Q2 | $3.87M | Buy |
23,364
+135
| +0.6% | +$21.8K | 0.41% | 55 |
|
|
2023
Q1 | $3.6M | Sell |
23,229
-6,430
| -22% | -$1.04M | 0.4% | 59 |
|
|
2022
Q4 | $5.24M | Sell |
29,659
-560
| -2% | -$96.7K | 0.59% | 44 |
|
|
2022
Q3 | $4.94M | Sell |
30,219
-3,481
| -10% | -$589K | 0.66% | 38 |
|
|
2022
Q2 | $5.98M | Sell |
33,700
-2,028
| -6% | -$361K | 0.76% | 33 |
|
|
2022
Q1 | $6.33M | Sell |
35,728
-17,951
| -33% | -$3.05M | 0.69% | 42 |
|
|
2021
Q4 | $9.18M | Buy |
53,679
+32
| +0.1% | +$5.24K | 1% | 23 |
|
|
2021
Q3 | $8.66M | Buy |
53,647
+2,132
| +4% | +$364K | 1.09% | 22 |
|
|
2021
Q2 | $8.49M | Sell |
51,515
-55
| -0.1% | -$9.11K | 1.09% | 24 |
|
|
2021
Q1 | $8.47M | Sell |
51,570
-71
| -0.1% | -$11.5K | 1.22% | 20 |
|
|
2020
Q4 | $8.13M | Sell |
51,641
-1,603
| -3% | -$237K | 1.25% | 19 |
|
|
2020
Q3 | $7.93M | Sell |
53,244
-4,211
| -7% | -$623K | 1.33% | 16 |
|
|
2020
Q2 | $8.08M | Sell |
57,455
-4,684
| -8% | -$683K | 1.46% | 16 |
|
|
2020
Q1 | $8.15M | Buy |
62,139
+681
| +1% | +$96.6K | 1.63% | 15 |
|
|
2019
Q4 | $9.07M | Sell |
61,458
-49
| -0.1% | -$6.65K | 1.5% | 16 |
|
|
2019
Q3 | $7.96M | Sell |
61,507
-5,418
| -8% | -$714K | 1.48% | 17 |
|
|
2019
Q2 | $9.32M | Buy |
66,925
+78
| +0.1% | +$10.8K | 1.64% | 13 |
|
|
2019
Q1 | $9.34M | Buy |
66,847
+166
| +0.2% | +$22.2K | 1.74% | 10 |
|
|
2018
Q4 | $8.61M | Sell |
66,681
-1,692
| -2% | -$236K | 1.81% | 9 |
|
|
2018
Q3 | $9.45M | Sell |
68,373
-16,656
| -20% | -$2.21M | 1.68% | 8 |
|
|
2018
Q2 | $10.3M | Buy |
85,029
+512
| +0.6% | +$63.9K | 1.95% | 7 |
|
|
2018
Q1 | $10.8M | Buy |
84,517
+2,203
| +3% | +$298K | 2.53% | 4 |
|
|
2017
Q4 | $11.5M | Buy |
82,314
+237
| +0.3% | +$33K | 2.2% | 2 |
|
|
2017
Q3 | $10.7M | Sell |
82,077
-147
| -0.2% | -$19.5K | 2.2% | 2 |
|
|
2017
Q2 | $10.9M | Buy |
82,224
+8,200
| +11% | +$1.05M | 2.35% | 2 |
|
|
2017
Q1 | $9.22M | Buy |
74,024
+18,070
| +32% | +$2.16M | 2.23% | 2 |
|
|
2016
Q4 | $6.45M | Buy |
55,954
+1,728
| +3% | +$200K | 1.87% | 6 |
|
|
2016
Q3 | $6.41M | Buy |
54,226
+5,653
| +12% | +$686K | 2.13% | 2 |
|
|
2016
Q2 | $5.89M | Buy |
48,573
+2,327
| +5% | +$264K | 2.24% | 2 |
|
|
2016
Q1 | $5M | Buy |
46,246
+2,029
| +5% | +$210K | 2.19% | 3 |
|
|
2015
Q4 | $4.54M | Buy |
44,217
+4,660
| +12% | +$469K | 2.19% | 4 |
|
|
2015
Q3 | $3.69M | Buy |
39,557
+2,379
| +6% | +$230K | 2.09% | 5 |
|
|
2015
Q2 | $3.62M | Sell |
37,178
-854
| -2% | -$85.5K | 2.03% | 6 |
|
|
2015
Q1 | $3.83M | Buy |
38,032
+1,764
| +5% | +$179K | 2.27% | 5 |
|
|
2014
Q4 | $3.79M | Sell |
36,268
-520
| -1% | -$54.8K | 2.37% | 4 |
|
|
2014
Q3 | $3.92M | Buy |
36,788
+589
| +2% | +$61.1K | 2.62% | 3 |
|
|
2014
Q2 | $3.79M | Sell |
36,199
-2,406
| -6% | -$243K | 2.62% | 5 |
|
|
2014
Q1 | $3.79M | Buy |
38,605
+2,578
| +7% | +$239K | 2.69% | 4 |
|
|
2013
Q4 | $3.3M | Buy |
+36,027
| New | +$3.32M | 2.62% | 5 |
|
Other funds holding JNJ
Girard Partners's JNJ Position: Q2 2024 in Review
Girard Partners reduced its Johnson & Johnson (JNJ) stake by 4.3% in Q2 2024, selling an estimated $147K and leaving 21,976 shares worth $3.21M. The position accounts for 0.3% of the portfolio, ranked #66.
Girard Partners first reported a position in JNJ in Q4 2013 and has held it in 43 quarters since. The position peaked at $11.5M in Q4 2017. 3,801 funds tracked by Wall St. Rank hold JNJ as of Q2 2024.
- Girard Partners held 21,976 shares of Johnson & Johnson worth $3.21M as of Q2 2024.
- Girard Partners sold 991 Johnson & Johnson shares in Q2 2024, an estimated $147K.
- Johnson & Johnson made up 0.3% of Girard Partners's portfolio in Q2 2024, its #66 holding.
- Girard Partners first reported a position in Johnson & Johnson in Q4 2013 and has held it in 43 quarters since.
- Girard Partners's Johnson & Johnson position peaked at $11.5M in Q4 2017.
- 3,801 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2024.
Based on Girard Partners's 13F filing for Q2 2024, filed 12 Aug 2024.